Revenue and profitability
- Revenue: $3,886,100 for QQ2 2025, YoY change: -62.4%, QoQ change: -66.6%.
- Gross Profit: $3,886,100; Gross Margin: 100.00% (note: cost of revenue data is not provided, so margin interpretation is provisional).
- Operating Income: $944,185; Operating Margin: 24.30% (ratio based on reported figures).
- EBITDA: $944,185; EBITDA Margin: 24.30%.
- Total Other Income/Expenses: $307,871; Income Before Tax: $1,252,056; Income Tax Expense: $195,896; Net Income: $1,056,160; Net Margin: 27.18%; EPS: $0.34.
- YoY and QoQ momentum: Net income YoY -46.69%, QoQ -60.39%; EPS YoY -47.69%, QoQ -60.00%.
Liquidity and cash flow
- Operating Cash Flow: $3,589,497; Free Cash Flow: $3,836,459; Capex: $246,962.
- Change in Working Capital: $6,641,886; Accounts Receivables: -$1,468,126; Inventory: -$600,741; Accounts Payables: -$990,571; Other Working Capital: $9,701,324; Other Non-Cash Items: -$4,556,214.
- Net Cash Provided by Operating Activities: $3,589,497; Net Cash Used for Investing Activities: $1,459; Net Cash Used Provided by Financing Activities: $87,259; Net Change in Cash: $191,837.
- Cash and Equivalents at End of Period: $2,355,333; Beginning Cash: $2,163,496; Net Debt: -$2,355,333 (net cash position).
Balance sheet health
- Total Assets: $60,908,041; Total Current Assets: $48,577,323; Total Current Liabilities: $7,062,755; Total Liabilities: $5,109,064; Total Stockholders’ Equity: $55,798,977; No long-term debt reported.
- Liquidity ratios: Current 6.88x; Quick 5.66x; Cash Ratio 0.33x.
- Capital structure: Debt to equity and debt to capitalization are effectively zero; company appears financially net cash positive.
- Activity metrics: DSO 260.9 days; Inventory Days 0 (data limitation); Receivables Turnover 0.345x; Asset Turnover 0.064; ROE 1.89%; ROA 1.73%; Payout ratio 0%.
Valuation and market context
- Price-to-book 2.68x; Price-to-sales 38.43x; Price-to-earnings 35.35x; Enterprise value multiple 155.69x (based on available peer data and reported metrics). These multiples reflect a market with either limited public comparables or a premium for Taylor’s niche capabilities in seismic dampers, shock absorption, and defense applications, but given the top-line decline the current multiples warrant scrutiny until revenue stabilization occurs.